+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The Subarachnoid Space: Percutaneous Access for Diagnosis and Image-Guided therapies, An Issue of Neuroimaging Clinics of North America. The Clinics: Radiology Volume 35-1

  • Book

  • February 2025
  • Region: North America
  • Elsevier Health Science
  • ID: 6006167
In this issue of Neuroimaging Clinics, guest editors Drs. Bryan Lanzman and Tarik F. Massoud bring their considerable expertise to the topic of The Subarachnoid Space: Percutaneous Access for Diagnosis and Image-Guided Therapies. In this first-of-its-kind issue, top experts the field discuss a wide range of topics related to the subarachnoid space, including imaging anatomy, guided lumbar punctures, puncture complications, myelography, cisternography, and much more.
  • Contains 12 relevant, practice-oriented topics including imaging anatomy of cerebrospinal fluid spaces; standard fluoroscopic and CT-guided lumbar punctures; fluoroscopic, CT, and MR myelography; CT and MR cisternography; lumbar puncture, myelography, and cisternography in children; and more.
  • Provides in-depth clinical reviews on the subarachnoid space, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Authors

Bryan Lanzman Assistant Professor, Division of Neuroimaging and Neurointervention, Department of Radiology, Stanford University School of Medicine, Stanford, California, USA. Tarik F. Massoud Professor, Division of Neuroimaging and Neurointervention, Department of Radiology, Stanford University School of Medicine, Stanford, California, USA. Dr. Massoud has expertise in molecular imaging, translational cancer imaging, neuro-oncology, and applications and perspectives relevant to clinical cancer management of glioblastoma patients.